ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 42 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $5,000 | +25.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -42.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | +16.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 90,000 | $222,000 | 0.17% |
| EQUITEC SPECIALISTS, LLC | 21,820 | $54,000 | 0.02% |
| TFS CAPITAL LLC | 46,886 | $116,000 | 0.01% |
| Westend Capital Management, LLC | 1,000 | $3,000 | 0.00% |
| A.R.T. Advisors, LLC | 33,414 | $82,000 | 0.00% |
| Virtu KCG Holdings LLC | 31,765 | $78,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,080 | $35,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,115 | $2,754,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,489 | $374,000 | 0.00% |
| BlackRock Investment Management, LLC | 73,717 | $182,000 | 0.00% |